News
MyChesCo on MSN11h
Madrigal Pharmaceuticals Secures EU Approval for First-Ever MASH Therapy
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has announced that the European Commission (EC) has granted conditional ...
18h
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback